Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Machado FS, Dutra WO, Esper L, Gollob KJ, Teixeira MM, Factor SM, Weiss LM, Nagajyothi F, Tanowitz HB, Garg NJ.

Semin Immunopathol. 2012 Nov;34(6):753-70. doi: 10.1007/s00281-012-0351-7. Epub 2012 Oct 18. Review.

2.

[Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].

Laucella SA, Rottenberg ME, de Titto EH.

Rev Argent Microbiol. 1996 Apr-Jun;28(2):99-109. Review. Spanish.

PMID:
8768488
3.

Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.

Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, James MA.

Am J Trop Med Hyg. 1998 Jan;58(1):119-21.

4.

Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.

Brener Z, Gazzinelli RT.

Int Arch Allergy Immunol. 1997 Oct;114(2):103-10. Review.

PMID:
9338602
5.

Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.

Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Perez AR, Aoki Mdel P, Bottasso O, Guiñazú N, Silva-Barbosa SD, Gea S.

Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):107-24. Epub 2007 Mar 6. Review.

PMID:
17339126
6.

Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity.

Mello DB, Ramos IP, Mesquita FC, Brasil GV, Rocha NN, Takiya CM, Lima AP, Campos de Carvalho AC, Goldenberg RS, Carvalho AB.

PLoS Negl Trop Dis. 2015 Aug 6;9(8):e0003945. doi: 10.1371/journal.pntd.0003945. eCollection 2015.

8.

The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.

Junqueira C, Caetano B, Bartholomeu DC, Melo MB, Ropert C, Rodrigues MM, Gazzinelli RT.

Expert Rev Mol Med. 2010 Sep 15;12:e29. doi: 10.1017/S1462399410001560. Review.

PMID:
20840799
9.

Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).

Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC, Factor SM, Kirchhoff LV, Weiss LM.

Prog Cardiovasc Dis. 2009 May-Jun;51(6):524-39. doi: 10.1016/j.pcad.2009.02.001. Review.

10.

Innate and acquired immunity in the pathogenesis of Chagas disease.

Golgher D, Gazzinelli RT.

Autoimmunity. 2004 Aug;37(5):399-409. Review.

PMID:
15621564
11.

The innate immune response to Trypanosoma cruzi infection.

Kayama H, Takeda K.

Microbes Infect. 2010 Jul;12(7):511-7. doi: 10.1016/j.micinf.2010.03.005. Epub 2010 Mar 27. Review.

PMID:
20348008
12.

Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Bryan MA, Guyach SE, Norris KA.

PLoS Negl Trop Dis. 2010 Jul 6;4(7):e733. doi: 10.1371/journal.pntd.0000733.

13.

Bioactive lipids in Trypanosoma cruzi infection.

Machado FS, Mukherjee S, Weiss LM, Tanowitz HB, Ashton AW.

Adv Parasitol. 2011;76:1-31. doi: 10.1016/B978-0-12-385895-5.00001-3. Review.

14.

The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.

Pellegrini A, Guiñazu N, Giordanengo L, Cano RC, Gea S.

Future Microbiol. 2011 Dec;6(12):1521-33. doi: 10.2217/fmb.11.122. Review.

PMID:
22122446
15.

Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?

Sathler-Avelar R, Vitelli-Avelar DM, Teixeira-Carvalho A, Martins-Filho OA.

Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:246-51. Review.

16.

Immunity and immune modulation in Trypanosoma cruzi infection.

Cardillo F, de Pinho RT, Antas PR, Mengel J.

Pathog Dis. 2015 Dec;73(9):ftv082. doi: 10.1093/femspd/ftv082. Epub 2015 Oct 4. Review.

PMID:
26438729
17.

Update on Chagas' disease in Mexico.

Dumonteil E.

Salud Publica Mex. 1999 Jul-Aug;41(4):322-7. Review.

PMID:
10624144
18.

Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence.

Fernandes MC, Andrews NW.

FEMS Microbiol Rev. 2012 May;36(3):734-47. doi: 10.1111/j.1574-6976.2012.00333.x. Epub 2012 Mar 13. Review.

19.

Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.

Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, Alvarez-Leite JI, Ropert C, Gazzinelli RT.

J Immunol. 2004 Feb 1;172(3):1711-8.

20.

Trypanosoma cruzi infection results in an increase in intracellular cholesterol.

Johndrow C, Nelson R, Tanowitz H, Weiss LM, Nagajyothi F.

Microbes Infect. 2014 Apr;16(4):337-44. doi: 10.1016/j.micinf.2014.01.001. Epub 2014 Jan 28.

Items per page

Supplemental Content

Write to the Help Desk